Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06965192

Designing Visual Tools to Enhance Cancer Surgeon Decision-making

Led by UNC Lineberger Comprehensive Cancer Center · Updated on 2025-12-05

220

Participants Needed

2

Research Sites

144 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This prospective study will compare pre-post pilot test of surgeon-facing, visual decision support among urologists seeing patients with newly diagnosed localized prostate and kidney cancer. Up to 20 urologists (10 academic and 10 community) will be enrolled. The goal will be to capture up to 10 pre- and 10 post-intervention patient encounters for each urologist with an accrual target of 200 unique patient visits (100 pre and 100 post-intervention) over a half-year period. Patient encounters pre- and post-intervention will be audio recorded, transcribed, and coded for discussion of risks/benefits of surgery and strength of recommendation. Patients and urologists will complete additional surveys on their perceptions of patient-provider communication. Urologists will further describe their experience and rate their satisfaction with visual decision support. Communication (content and perceived) will be compared pre- and post-intervention with secondary comparisons by race and care setting. It was hypothesized that the discussion of risks and benefits of cancer surgery will increase post-intervention and that the strength of recommendation and perceptions of patient-provider communication will change. The secondary hypothesis is that these changes will differ by patient race and care setting.

CONDITIONS

Official Title

Designing Visual Tools to Enhance Cancer Surgeon Decision-making

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Verbal informed consent was obtained to participate in the study.
  • Subject is willing and able to comply with study procedures based on investigator judgment.
  • Age 18 years or older at the time of consent.
  • For patients: new histologic diagnosis of localized prostate cancer based on biopsy or clinical diagnosis of T1 renal mass (7 cm or smaller) suspicious for kidney cancer within 6 months of consent.
  • For physicians: practicing urologist in North Carolina at UNC Health, Novant Health, or affiliated sites who sees patients with suspected or confirmed prostate or kidney cancer.
Not Eligible

You will not qualify if you...

  • Non-English speaking.
  • Unwilling or unable to complete informed consent.
  • For patients: staging indicating locally advanced or metastatic disease, including PSA over 50 ng/ml, imaging showing distant metastasis or lymph node involvement, renal masses larger than 7 cm, invasion of renal sinus, or tumor thrombus.
  • Histologic or clinical diagnosis more than 6 months before consent.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

UNC Lineberger Comprehensive Cancer Center

Chapel Hill, North Carolina, United States, 27599

Actively Recruiting

2

New Hanover Regional Medical Center

Wilmington, North Carolina, United States, 28401

Not Yet Recruiting

Loading map...

Research Team

D

Deborah Usinger

CONTACT

T

Taylor Greene

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

CROSSOVER

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here